1. Screening the Expression Changes in MicroRNAs and Their Target Genes in Mature Cementoblasts Stimulated with Cyclic Tensile Stress
    Liao Wang et al, 2016, IJMS CrossRef
  2. Isoalantolactone inhibits the migration and invasion of human breast cancer MDA-MB-231 cells via suppression of the p38 MAPK/NF-κB signaling pathway.
    Jing Wang et al, 2016, Oncol Rep CrossRef
  3. Current updates on microRNAs as regulators of chemoresistance
    Metin Çalışkan et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  4. Potential therapeutic implications of miRNAs in osteosarcoma chemotherapy
    Dan Chen et al, 2017, Tumour Biol. CrossRef
  5. The vitamin D receptor regulates miR-140-5p and targets the MAPK pathway in bone development
    Wenting Luo et al, 2018, Metabolism CrossRef
  6. MiR-92a Inhibits the Progress of Osteosarcoma Cells and Increases the Cisplatin Sensitivity by Targeting Notch1
    Quanxiang Liu et al, 2018, BioMed Research International CrossRef
  7. Cytokine-mediated modulation of the hepatic miRNome: miR-146b-5p is an IL-6-inducible miRNA with multiple targets
    Mélanie Kirchmeyer et al, 2018, J Leukoc Biol CrossRef
  8. p16INK4a inhibits the proliferation of osteosarcoma cells through regulating the miR-146b-5p/TRAF6 pathway
    Mingwei Jiang et al, 2019, Biosci. Rep. CrossRef
  9. MicroRNAs in Bone Metastasis
    Eric Hesse et al, 2019, Curr Osteoporos Rep CrossRef
  10. miRNA signatures in childhood sarcomas and their clinical implications
    G. M. Viera et al, 2019, Clin Transl Oncol CrossRef
  11. MicroRNA-146b Overexpression Promotes Human Bladder Cancer Invasion via Enhancing ETS2-Mediated mmp2 mRNA Transcription.
    Junlan Zhu et al, 2019, Mol Ther Nucleic Acids CrossRef
  12. LncRNA SOX2‐OT regulates proliferation and metastasis of nasopharyngeal carcinoma cells through miR‐146b‐5p/HNRNPA2B1 pathway
    Enqin Zhang et al, 2019, J Cell Biochem CrossRef
  13. Genetic factors conferring metastasis in osteosarcoma
    Vadim V Maximov et al, 2016, Future Oncology CrossRef
  14. MicroRNA‐146b overexpression associates with deteriorated clinical characteristics, increased International Staging System stage, cacoethic chromosome abnormality, and unfavorable prognosis in multiple myeloma patients
    Ying Bao et al, 2020, J Clin Lab Anal CrossRef
  15. Nanomedicine in osteosarcoma therapy: micelleplexes for delivery of nucleic acids and drugs for osteosarcoma-targeted therapy
    Miguel Pereira-Silva et al, 2020, European Journal of Pharmaceutics and Biopharmaceutics CrossRef
  16. Down-regulation of miR-146b-5p by long noncoding RNA MALAT1 in hepatocellular carcinoma promotes cancer growth and metastasis
    Chao Li et al, 2017, Oncotarget CrossRef
  17. The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancer
    Yin Peng et al, 2017, Oncotarget CrossRef
  18. Noncoding RNA in drug resistant sarcoma
    Xiaoyang Li et al, 2017, Oncotarget CrossRef
  19. Bone Microenvironment and Osteosarcoma Metastasis
    Chaofei Yang et al, 2020, IJMS CrossRef
  20. Advances in the role of miRNAs in the occurrence and development of osteosarcoma
    Guanyu Zhang et al, 2020 CrossRef
  21. A Genetic Variant Located in miR-146b Promoter Region Is Associated with Prognosis of Gastric Cancer
    Weizhi Wang et al, 2018, Cancer Epidemiol Biomarkers Prev CrossRef
  22. Low Protein Expression of both ATRX and ZNRF3 as Novel Negative Prognostic Markers of Adult Adrenocortical Carcinoma
    Vania Balderrama Brondani et al, 2021, IJMS CrossRef
  23. Noncoding RNAs in osteosarcoma: Implications for drug resistance
    Zhengjun Lin et al, 2021, Cancer Letters CrossRef
  24. The role of miRNAs and lncRNAs in conferring resistance to doxorubicin
    Mohammad Taheri et al, 2021, Journal of Drug Targeting CrossRef
  25. Research Progress of MicroRNA in Chemotherapy Resistance of Osteosarcoma
    Zhaopeng Tang et al, 2021, Technol Cancer Res Treat CrossRef
  26. Targeting Wnt/β-catenin signaling by microRNAs as a therapeutic approach in chemoresistant osteosarcoma
    Foroogh Hosseini et al, 2021, Biochemical Pharmacology CrossRef
  27. MicroRNA-146b-5p suppresses cholangiocarcinoma cells by targeting TRAF6 and modulating p53 translocation
    Yiyue Ren et al, 2021, Acta Histochemica CrossRef
  28. Preparation of polycation with hydroxyls for enhanced delivery of miRNA in osteosarcoma therapy
    Da-Fu Chen et al, 2022, Biomater. Sci. CrossRef
  29. MicroRNAs and osteosarcoma: Potential targets for inhibiting metastasis and increasing chemosensitivity
    Negin Soghli et al, 2022, Biochemical Pharmacology CrossRef
  30. Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA
    Hefen Chen et al, 2024, Drug Development Research CrossRef
  31. Combining serum microRNAs and machine learning algorithms for diagnosing infectious fever after HSCT
    Wenwei Shao et al, 2024, Ann Hematol CrossRef
  32. Targeting the Wnt/β-Catenin Cascade in Osteosarcoma: The Potential of ncRNAs as Biomarkers and Therapeutics
    Shivkanya Fuloria et al, 2024, Pathology - Research and Practice CrossRef
  33. miR-146b-5p Regulates the Enteric Nervous System Development in Hirschsprung Disease via Targeting RET Pathway
    Bobin Zhang et al, 2024, Biochem Genet CrossRef